Papayannidis, C <br/><br/>
A Phase 1 study of the novel gamma-secretase inhibitor PF-03084014 in patients with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma.  [electronic resource] 

 -  Blood cancer journal  Sep 2015 
 - e350 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Letter; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2044-5385 
<br/><br/><label>Standard No.: </label>10.1038/bcj.2015.80  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antineoplastic Agents--pharmacokinetics<br/>Female<br/>High-Throughput Nucleotide Sequencing<br/>Humans<br/>Male<br/>Precursor T-Cell Lymphoblastic Leukemia-Lymphoma--drug therapy<br/>Receptor, Notch1--genetics<br/>Tetrahydronaphthalenes--therapeutic use<br/>Valine--analogs & derivatives<br/>Young Adult